It affects about 25% Canadian adults and because it is closely linked with obesity and type 2 diabetes, treatment typically includes lifestyle interventions to reduce weight
Generally speaking, improvements were noted in special learning tasks, timed tasks of attention, discrimination- learning tasks, and tasks of personal recognition
These include the cost of the medication, potential side effects such as gastrointestinal disturbances and increased risk of thyroid tumors, the unestablished long-term safety in non-diabetic individuals, and limited availability due to high demand
[9] [12] The FDA has approved various formulations for different indications, with growing clinical use across multiple patient populations
GLP-1 receptor agonists could be transformative for populations disproportionately affected by obesity, says Stokes, principal investigator of the grant
a bedtime multivitamin taken at least two hours after the last dose is advised to offset this risk